Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Copolymer 1 inhibits manifestations of graft rejection.
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Idebenone for primary progressive multiple sclerosis
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
First proof for rituximab in IgG4-related disease
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Ustekinumab.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
The role of T cell apoptosis in nervous system autoimmunity.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.

Pages